Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Chronic Kidney Disease Not Using RAS Inhibitors
NCT07181135Phase 3Enrolling by invitation
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finerenone in chronic kidney disease (CKD), sponsored by University Medical Center Groningen. Started Mar 2026; status: enrolling by invitation.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07181135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07181135.